ADVERTISEMENT

Piramal Pharma Listing On Bourses: All You Need To Know

Get all the details regarding Piramal Pharma Ltd. and its listing on the Indian stock exchanges.

<div class="paragraphs"><p>Source: Twitter&nbsp;@PiramalPharma</p></div>
Source: Twitter @PiramalPharma

With the demerger of Piramal Pharma Ltd. from Piramal Enterprises Ltd., the company has now made its debut on the Indian stock markets. The pharma stock listed on the stock exchanges on October 19, 2022 at ₹201.8 per share on the Bombay Stock Exchange (BSE) and at ₹200 per share on the National Stock Exchange (NSE).

Suggested Read: Piramal Pharma Shares Fall After Listing At Rs 201.8 Post Demerger

Demerger Of Piramal Pharma Ltd. From Piramal Enterprises Ltd.

In August 2022, the National Company Law Tribunal (NCLT) approved the demerger of the pharma business of Piramal Enterprises Ltd. (PEL) to simplify the company’s corporate structure. The pharma company said that the demerger from Piramal Enterprises Ltd. will help them be fully ready for the future and enable them to pursue growth strategies independently with a sharper focus and identity,

Following the demerger, the Securities and Exchange Board of India (SEBI) provided the company with the approval to list the shares of Piramal Pharma Ltd. (PPLPHARMA) on the NSE and BSE. As per the demerger scheme, each shareholder of PEL will get 4 fully paid-up equity shares of PPLPHARMA at a face value of ₹10 per share against 1 share of PEL with a face value of ₹2 each.

About Piramal Pharma Ltd.

The pharma company currently offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities in 15 global facilities and has a global distribution network across more than 100 countries. Piramal Pharma includes the following:

  • Piramal Pharma Solutions (PPS)- an integrated Contract Development and Manufacturing Organisation (CDMO)

  • Piramal Critical Care (PCC)- a Complex Hospital Generics (CHG) business

  • India Consumer Healthcare (ICH) business that sells over-the-counter medical products.

Piramal Pharma Ltd. Stock Listing

On October 14, 2022, the SEBI gave a nod for the listing of the shares of Piramal Pharma Ltd. on the NSE and BSE. A notice issued by BSE regarding the listing of Piramal Enterprises read “Trading members of the exchange are hereby informed that effective from October 19, 2022, the equity shares of Piramal Pharma Limited shall be listed and admitted to dealings on the exchange in the list of T Group of Securities."

On its debut in the Indian stock exchanges, the shares of Piramal Pharma Ltd. opened at ₹201.8 per share on the Bombay Stock Exchange (BSE) and at ₹200 per share on the National Stock Exchange (NSE). However, the Piramal Pharma share price fell as low as 5% to close at ₹191.75 per share on BSE and at ₹190 per share on NSE.